ERYTHROPOIETIC PROTOPORPHYRIA - CLINICAL FEATURES AND TREATMENT

被引:0
|
作者
BECKERT, E [1 ]
METZ, J [1 ]
机构
[1] UNIV WURZBURG,DERMATOL KLIN & POLIKLIN,D-8700 WURZBURG,FED REP GER
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1981 / &
相关论文
共 50 条
  • [1] CLINICAL ASPECTS, DIAGNOSIS AND TREATMENT OF ERYTHROPOIETIC PROTOPORPHYRIA
    AKIMOV, VG
    [J]. VRACHEBNOE DELO, 1987, (07): : 86 - 88
  • [2] The treatment of erythropoietic protoporphyria
    Mathews-Roth, MM
    [J]. SEMINARS IN LIVER DISEASE, 1998, 18 (04) : 425 - 426
  • [3] Treatment for erythropoietic protoporphyria
    Langendonk, J. G.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (06) : 1481 - 1482
  • [4] Erythropoietic protoporphyria in the UK: clinical features and effect on quality of life
    Holme, S. A.
    Anstey, A. V.
    Finlay, A. Y.
    Elder, G. H.
    Badminton, M. N.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (03) : 574 - 581
  • [5] PHOTOSENSITIVITY - FAMILIAL INCIDENCE, CLINICAL FEATURES AND INCIDENCE OF ERYTHROPOIETIC PROTOPORPHYRIA
    PRENTICE, RT
    GOLDBERG, A
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1969, 81 (06) : 414 - &
  • [6] ERYTHROPOIETIC PROTOPORPHYRIA - DIAGNOSIS AND TREATMENT
    MATHEWSROTH, MM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (02): : 98 - 100
  • [7] The treatment of erythropoietic protoporphyria - Response
    Cox, TM
    Norris, PGN
    [J]. SEMINARS IN LIVER DISEASE, 1998, 18 (04) : 426 - 426
  • [8] TREATMENT OF ERYTHROPOIETIC PROTOPORPHYRIA WITH HYDROXYETHYLRUTOSIDES
    SCHOEMAKER, JH
    BOUSEMA, MT
    ZIJLSTRA, H
    VANDERHORST, FAL
    [J]. DERMATOLOGY, 1995, 191 (01) : 36 - 38
  • [9] Erythropoietic protoporphyria in the Netherlands: Clinical features, psychosocial impact and the effect of afamelanotide
    Wensink, Debby
    Wagenmakers, Margreet A. E. M.
    Wilson, J. H. Paul
    Langendonk, Janneke G.
    [J]. JOURNAL OF DERMATOLOGY, 2023, 50 (04): : 445 - 452
  • [10] Afamelanotide for the treatment of erythropoietic protoporphyria
    Minder, Elisabeth Irene
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (04): : 341 - 349